What is the dosage for stanozolol

I am very knee to buy this product but before that i have few doubt,
1,I weight up to 85kgs so how many pills i need to take per day if i want to reduce in 3 to 4 months?
2. And is obviously i cant take this pills for life long so if i stop this pills once i lose weight id there any side effects cos i heard after stopping the consumption of few supplements there will be drastic change in weight gain so can u suggest me on this how to stop the pills once weight reduces?
3. So is there is any side effects like hair loss skin probe an all?
4. i may plan for pregnancy after few months so it does’t effect my pregnancy r my months periods?

1 Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (Hrsg.) „Referenzwerte für die Nährstoffzufuhr“ 1. Auflage, 5., korrigierter Nachdruck, DGE, Bonn 2013 http:///?name=Content&pa=showpage&pid=3&page=7
2 http:///lifestyle/nutrition/
3 Mustafa Vakur Bor, Kristina M von Castel-Roberts, Gail PA Kauwell, Sally P Stabler, Robert H Allen, David R Maneval, Lynn B Bailey Ebba Nexo „Daily intake of 4 to 7 µg dietary vitamin B-12 is associated with steady concentrations of vitamin B-12–related biomarkers in a healthy young population“ Am J Clin Nutr 2010 91: 3 571-577; First published online January 13, 2010. doi:/.
4 Berlin, H., Berlin, R. and Brante, G. (1968), ORAL TREATMENT OF PERNICIOUS ANEMIA WITH HIGH DOSES OF VITAMIN B12 WITHOUT INTRINSIC FACTOR. Acta Medica Scandinavica, 184: 247–258. doi: /-
5 ANDRÈS, E., DALI-YOUCEF, N., VOGEL, T., SERRAJ, K. and ZIMMER, J. (2009), Oral cobalamin (vitamin B12) treatment. An update. International Journal of Laboratory Hematology, 31: 1–8. doi: /-
6 Barbara M Rhode et al. Treatment of Vitamin B12 Deficiency after Gastric Surgery for Severe Obesity. Obesity Surgery May 1995, Volume 5, Issue 2, pp 154-158
7 C. Poitou Bernert, C. Ciangura, M. Coupaye, S. Czernichow, . Bouillot, A. Basdevant, Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment, Diabetes & Metabolism, Volume 33, Issue 1, February 2007, Pages 13-24, ISSN 1262-3636, http:////.
8 Eussen SM, de Groot LM, Clarke R, et al. Oral Cyanocobalamin Supplementation in Older People With Vitamin B12 Deficiency: A Dose-Finding Trial. Arch Intern Med. 2005;165(10):1167-1172. doi:/.
9 Sharabi, A., Cohen, E., Sulkes, J. and Garty, M. (2003), Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route. British Journal of Clinical Pharmacology, 56: 635–638. doi: /-
10 Georges Delpre, Pinhas Stark, Yaron Niv, Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation, The Lancet, Volume 354, Issue 9180, 28 August 1999, Pages 740-741, ISSN 0140-6736, http:////S0140-6736(99)02479-4.

The main side effect of this medication is sleep and rest, which plays a very important role in the healing process. Usually, within an hour or so after taking a dose, the oil is telling you to lay down and relax. Don’t try to fight the oils sleepy effects, just lay down and get comfortable, then allow the oil to give you the rest and relaxation you require to heal properly. The effects of the oil may cause your mind to wander a bit and often patients will be somewhat unsteady on their feet when they begin to use this medication. But as the patient builds up their tolerance, these effects will diminish quickly. Usually within 3 to 4 weeks, the daytime tiredness associated with this treatment after the patient takes their dosage just fades away, but the patient continues to sleep very well at night.

Administration advice :
-Extended/controlled/prolonged/sustained release tablet formulations should not be crushed or chewed.
-Take with food to decrease gastrointestinal side effects.
-This drug should be taken as the same time(s) each day.

Storage requirements :
-The manufacturer product information should be consulted.

General :
-Lithium toxicity is related to serum lithium levels, and may occur at doses close to therapeutic levels.
-Patients in the manic phase are better able to tolerate lithium; tolerance to lithium decreases when manic symptoms subside.
-Mania is characterized by pressure of speech, motor hyperactivity, reduced sleep requirements, flight of ideas, grandiosity, elation, poor judgment, aggressiveness, and/or hostility. Maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of the episodes.

Monitoring :
-ECG, especially in patients at risk of unmasking Brugada syndrome
-Thyroid function, especially in patients with thyroid disorders
-Lithium levels
-Renal function tests (., urinalysis, urine specific gravity, serum creatinine, creatinine clearance), especially in patients who develop polyuria and/or polydipsia

Patient advice :
-Patients should be told to seek immediate medical attention if signs/symptoms of Brugada syndrome, encephalopathic syndrome, or diabetes insipidus occur.
-Patients, family members, and/or caregivers should be instructed to discontinue therapy and immediately report any signs/symptoms of lithium toxicity, change in behavior, or suicidality.
-Inform patients that this drug may cause drowsiness, and they should avoid driving or operating machinery until the full effects of the drug are seen.
-Patients should be counseled on the importance of maintaining adequate salt and water intake.
-Advise patients to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.

What is the dosage for stanozolol

what is the dosage for stanozolol

Administration advice :
-Extended/controlled/prolonged/sustained release tablet formulations should not be crushed or chewed.
-Take with food to decrease gastrointestinal side effects.
-This drug should be taken as the same time(s) each day.

Storage requirements :
-The manufacturer product information should be consulted.

General :
-Lithium toxicity is related to serum lithium levels, and may occur at doses close to therapeutic levels.
-Patients in the manic phase are better able to tolerate lithium; tolerance to lithium decreases when manic symptoms subside.
-Mania is characterized by pressure of speech, motor hyperactivity, reduced sleep requirements, flight of ideas, grandiosity, elation, poor judgment, aggressiveness, and/or hostility. Maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of the episodes.

Monitoring :
-ECG, especially in patients at risk of unmasking Brugada syndrome
-Thyroid function, especially in patients with thyroid disorders
-Lithium levels
-Renal function tests (., urinalysis, urine specific gravity, serum creatinine, creatinine clearance), especially in patients who develop polyuria and/or polydipsia

Patient advice :
-Patients should be told to seek immediate medical attention if signs/symptoms of Brugada syndrome, encephalopathic syndrome, or diabetes insipidus occur.
-Patients, family members, and/or caregivers should be instructed to discontinue therapy and immediately report any signs/symptoms of lithium toxicity, change in behavior, or suicidality.
-Inform patients that this drug may cause drowsiness, and they should avoid driving or operating machinery until the full effects of the drug are seen.
-Patients should be counseled on the importance of maintaining adequate salt and water intake.
-Advise patients to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.

Media:

what is the dosage for stanozololwhat is the dosage for stanozololwhat is the dosage for stanozololwhat is the dosage for stanozololwhat is the dosage for stanozolol